|
Number
|
217
|
144
|
73
| |
|
Sex (male/female)
|
132/85
|
84/60
|
48/25
|
n.s.
|
|
Age median, (range) [years]
|
64 (18–90)
|
65 (20–90)
|
61 (18–85)
|
n.s.
|
|
APACHE-II score, median (range)
|
18 (2–43)
|
19 (4–43)
|
14 (2–33)
|
<0.001
|
|
SOFA score, median (range)
|
9 (0–17)
|
9 (2–17)
|
7 (0–17)
|
0.003
|
|
SAPS 2 score, median (range)
|
41 (0–73)
|
40 (0–73)
|
41 (0–73)
|
0.193
|
|
Mechanical ventilation, n (%)
|
144 (69)
|
98 (63)
|
46 (63)
|
n.s.
|
|
Ventilation time, median (range) [h]
|
117 (0–3828)
|
125.5 (0–2966)
|
66 (0–2828)
|
n.s.
|
|
Vasopressor demand, n (%)
|
132 (60.8)
|
99 (68.8)
|
33 (45.2)
|
<0.001
|
|
ICU days, median (range)
|
7 (1–137)
|
8.5 (1–137)
|
6 (1–45)
|
0.004
|
|
30-day mortality, n (%)
|
41 (18.9)
|
34 (23.6)
|
7 (9.6)
|
0.016
|
|
Overall mortality, n (%)
|
86 (41.7)
|
64 (46.7)
|
22 (31.9)
|
0.42
|
|
CT-proET-1, median (range) [pmol/L]
|
43.8 (3–503.6)
|
82.1 (3–503.6)
|
40.9 (3–372.9)
|
<0.001
|
|
Leucocytes, median (range) [per nL]
|
12.9 (0.5–208)
|
13.8 (0.5–208)
|
12.5 (1.8–29.6)
|
0.041
|
|
CRP, median (range) [mg/L]
|
98 (5–230)
|
160.5 (5–230)
|
17 (5–230)
|
<0.001
|
|
Cystatin C, median (range) [mg/L]
|
1.48 (0.39–8.38)
|
1.69 (0.39–8.38)
|
1.04 (0.56–2.29)
|
<0.001
|
|
Bilirubin, median (range) [per mg/dL]
|
0.7 (0.2–20.8)
|
0.7 (0.2–6.8)
|
0.7 (0.2–20.8)
|
n.s.
|
